ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Translation Pharma Limited

Translation Pharma Limited is a liquidation company incorporated on 18 November 2014 with the registered office located in Chatham, Kent. Translation Pharma Limited was registered 10 years ago.
Status
Liquidation
In voluntary liquidation since 1 year 4 months ago
Company No
09316639
Private limited company
Age
10 years
Incorporated 18 November 2014
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Overdue
Confirmation statement overdue by 346 days
Dated 18 November 2023 (1 year 12 months ago)
Next confirmation dated 18 November 2024
Was due on 2 December 2024 (11 months ago)
Last change occurred 6 years ago
Accounts
Submitted
For period 1 Dec31 Jan 2024 (1 year 2 months)
Accounts type is Total Exemption Full
Next accounts for period 31 January 2025
Was due on 31 October 2025 (13 days ago)
Address
C/O Begbies Traynor, Innovation Centre Medway
Maidstone Road
Chatham
Kent
ME5 9FD
Address changed on 3 Jul 2024 (1 year 4 months ago)
Previous address was Camburgh House, 27 New Dover Road Canterbury Kent CT1 3DN United Kingdom
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
4
Shareholders
4
Controllers (PSC)
1
Director • British • Lives in UK • Born in May 1974
Director • British • Lives in UK • Born in Oct 1972
Director • British • Lives in UK • Born in Mar 1960
Director • British • Lives in UK • Born in Jul 1960
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Sevenless Therapeutics Limited
Dr Alasdair Mark Naylor and Alexander Robert Leech are mutual people.
Active
Ensocell Ltd
Alexander Robert Leech is a mutual person.
Active
Forth Therapeutics Limited
Alexander Robert Leech is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Jan 2024
For period 1 Dec31 Jan 2024
Traded for 14 months
Cash in Bank
£330.07K
Decreased by £93.97K (-22%)
Turnover
Unreported
Same as previous period
Employees
4
Same as previous period
Total Assets
£452.64K
Decreased by £23.85K (-5%)
Total Liabilities
-£71.63K
Decreased by £70.45K (-50%)
Net Assets
£381.01K
Increased by £46.6K (+14%)
Debt Ratio (%)
16%
Decreased by 13.99% (-47%)
Latest Activity
Registered Address Changed
1 Year 4 Months Ago on 3 Jul 2024
Declaration of Solvency
1 Year 4 Months Ago on 3 Jul 2024
Voluntary Liquidator Appointed
1 Year 4 Months Ago on 3 Jul 2024
Full Accounts Submitted
1 Year 6 Months Ago on 3 May 2024
Accounting Period Extended
1 Year 6 Months Ago on 24 Apr 2024
Confirmation Submitted
1 Year 11 Months Ago on 28 Nov 2023
Full Accounts Submitted
2 Years 3 Months Ago on 27 Jul 2023
Confirmation Submitted
2 Years 11 Months Ago on 23 Nov 2022
Full Accounts Submitted
3 Years Ago on 30 Aug 2022
Confirmation Submitted
3 Years Ago on 23 Nov 2021
Get Credit Report
Discover Translation Pharma Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Return of final meeting in a members' voluntary winding up
Submitted on 19 Aug 2025
Appointment of a voluntary liquidator
Submitted on 3 Jul 2024
Declaration of solvency
Submitted on 3 Jul 2024
Registered office address changed from Camburgh House, 27 New Dover Road Canterbury Kent CT1 3DN United Kingdom to C/O Begbies Traynor, Innovation Centre Medway Maidstone Road Chatham Kent ME5 9FD on 3 July 2024
Submitted on 3 Jul 2024
Resolutions
Submitted on 3 Jul 2024
Total exemption full accounts made up to 31 January 2024
Submitted on 3 May 2024
Previous accounting period extended from 30 November 2023 to 31 January 2024
Submitted on 24 Apr 2024
Confirmation statement made on 18 November 2023 with no updates
Submitted on 28 Nov 2023
Total exemption full accounts made up to 30 November 2022
Submitted on 27 Jul 2023
Confirmation statement made on 18 November 2022 with no updates
Submitted on 23 Nov 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year